Our preliminary report on the treatment of diabetic maculopathy concerned 44 eyes in forty consecutive patients treated during the 2 years prior to January, I971 (Rubinstein andMyska, I972) . Duringthefollowing 2 years (untilJanuary, 1973) yet another 77 eyes (in 72 patients) have been treated in a similar manner, bringing our clinical material to I12 I eyes in I I 2 patients with a follow-up of between a maximum of 4 years and a minimum of 2 years for the previously reported group, and between 2 years and 6 months for the second. It is felt that such a number of clinical cases and the follow-up running into 4 years justify a re-assessment of the efficiency of this treatment and the validity of the principles on which it is based.
Working hypothesis
As a result of diabetic microangiopathy multiple foci of tissue hypoxia develop in the retina. An hypoxic focus of partially collapsed and abnormally permeable capillaries is flanked by abnormal blood shunting channels of variably thickened walls and variably uneven calibre, developing microaneurysms and unable to maintain the physiological blood-retina barrier. The result of these changes is an area of acidosis and tissue oedema spreading centrifugally and self-perpetuating. The abnormal vessel permeability to plasma causes-in the first instance-tissue oedema and, if increased, haemorrhages by red corpuscle diapedesis. Permeability to plasma lipids manifests itself as deposits of hard exudates, and new vessel formation results from stimuli not yet fully understood but likely to include hypoxia and lactic acid accumulation. The hypoxic focus ofdiabetic retinopathy seems to be the basic anatomical lesion and it carries a pathogenic potential (Fig. i) opposite).
There are four ways in which a macula may be affected by the presence of an hypoxic focus in its vicinity (being avascular the macula itself does not become the centre ofa primary hypoxic focus):
(a) By an advancing front of oedema; (b) By advancing new vessels; (c) By a haemorrhage; (d) By deposition of hard exudates.
The first sign of diabetic maculopathy is macular oedema. This is often compatible with a long period of retention of good central vision, but eventually sensory and pigment epithelial degeneration will take place with failing visual acuity. Any therapeutic interference to be effective would have to be early, before permanent anatomical damage to the macula had time to develop.
The primary aim of our treatment is to convert the hypoxic foci, which are threatening the macula by their advancing front, into anoxic foci-scars-which carry no such pathogenic potential (Rubinstein and Myska, 197I) . Closure of the diseased capillaries and new vessels at the centre of a focus lead to the absorption of oedema, hard exudates, and haemorrhages, and the closure of microaneurysms. In early cases with only one or two foci around the macula, a few photocoagulation burns suffice (direct approach) (Fig. 2) . A common remote hypoxic area is the temporal raphe which can be effectively and safely photocoagulated. This area often shows more extensive changes requiring six to twelve applications (paramacular approach) (Fig. 3) . In florid cases, where the whole perimacular area is studded with hypoxic foci which merge and lose their identity, such precise targeting may be impossible, and destruction of as many foci as practicable without depriving the macular retina of all circulation is performed by the use of perimacular multiple application along the arcuate perimacular vessels. About twenty to thirty applications are then required (perimacular approach) (Fig. 4) (Fig. 5) . The assessment of the retina and the choice of approach must be based on fluorescein angiography. This alone is capable of defining areas of circulatory disturbance requiring treatment as opposed to inactive exudates, haemorrhages, and microaneurysms which do not require direct destruction (Rubinstein, I969; Rubinstein and Myska, 1970) .
Clinical material Of more than 300 diabetics treated by light coagulation for retinopathy during the years I968 to 1972, I I2 were treated specifically for macular changes; in nine patients both eyes were treated. The The preoperative visual acuity of the treated eyes (Table I) shows a wide range of macular dysfunction, the mean visual acuity of the series falling just above 6/18. K. Rubinstein and V. Myska Selection and management of patients
The routine management of the patients-after earlier experimentation-was established as follows: Referred patients were seen by appointment and a decision was made as to their suitability for treatment. Those selected, and all doubtful cases, had fundus photography done and angiography of relevant retinal sectors-using 4 ml. IO per cent. fluorescein sodium intravenously-at that first visit. After the photographs and angiograms had been studied, a final decision was made about the feasibility and method of treatment.
The indication for treatment was the presence of subjective visual symptoms relating to macular involvement, however early (e.g. some distortion of vision even with visual acuity 6/5) or however late (e.g. visual acuity of I /6o), and the presence of macular pathology, however negligible (e.g. early oedema) or however advanced (pigment dystrophy, large hard deposits, heavy haemorrhagic involvement of all the central area).
The contraindications for treatment were: (a) A degree of lens sclerosis high enough to prevent clear observation and the prodution of an efficient retinal burn; (b) Pre-retinal membranes over areas requiring direct treatment; (c) Marked gliosis at and round the essential target areas.
All but ten operations were conducted on a day-patient basis. The exceptions were those patients who insisted on general anaesthesia, who were judged to require general anaesthesia because of obvious psychological instability, or who could not reach the hospital from home on the morning of the operation because of the distance involved. We do not consider it prudent-unless necessary-to admit diabetics into an eye unit.
All but four operations were done under local anaesthesia. Premedication with Droperidol 5 mg. and Phenoperidine o-5 mg. I hour before operation was followed in the light coagulation theatre with slow intravenous infusion of Valium (3 to 5 mg.) and retrobulbar injection of Lignocaine 3 ml.
These measures assured relaxation of the patients, often to the point of snoring, and an immobile eye often requiring no lid speculum and no fixation forceps for positioning. Occasional sliding of the upper lid over the cornea by the operator's finger maintains a moist and clear cornea. Most patients had none or only a vague memory of the procedure even in cases of maximum targeting. After light coagulation they were rested recumbent for 2 to 3 hours and then allowed to go home. The first postoperative checks were done within 7 days after treatment.
Instrumentation
Xenon light generated by the Zeiss (Oberkochen) instrument was used in the first part of this trial and that of the Log-2 O'Malley Coagulator in the second. Of the two the latter proved to be a much easier instrument to use and of equal efficiency. Particularly for the work near the macula, the O'Malley aperture 20 with appropriate power setting was much safer and more efficient than the Zeiss aperture I-5, mainly because of better visibility of the surrounding field, facilitating targeting. The time of a single application was never more than 2 sec., mostly less, and we aimed at definite lesions but of minimal strength. Table II shows the frequency of each of these approaches. Of the I 03 fellow eyes which were untreated, improvement by I line was shown by seven during the observation time. The preoperative visual acuity was maintained in 56; sixteen of these had vision i /6o or worse from the start. Forty eyes showed deterioration of visual acuity (2I by I line, eight by 2 lines, two by 3 lines, three by 4 lines, and six by 5 linesSnellen chart) (Table IV, overleaf).
FOLLOW-UP
We had no recurrence of macular oedema or vascular reactivation at the edges of treated target areas. In twelve cases second operations were deemed advisable (and performed): in 8Ii The analysis of visual changes did not, however, confirm this assumption: the earlier, 2 to 4 years follow-up group, did better than the later, 6 months to 2 years follow-up group (Fig.   6 , opposite).
One may speculate that the full recovery of macular function after the elimination of twilight circulation areas around the macula and breaking down of a vicious circle of localized metabolic embarrassment may require a longer time even than 2 years.
Discussion
Of the I 21 treated eyes, I 12 retained their visual acuity or improved, halfof them markedly, and nine became worse (four from preoperative progressive cataract). Of the I 03 untreated eyes, 56 retained their visual acuity and seven slightly improved, whilst forty suffered deterioration of vision, half of them severe. These clinical observations allow us very little doubt as to the usefulness of our method of treatment. Moreover, the follow-up time extending up to 4 years demonstrated a widening gap between the fate of the treated v. the untreated eyes.
Considering only the patients who stayed in the paired-eye trial, elimination of the nine cases treated bilaterally leaves us with I03 patients whose worse eye was treated, the other having been left alone as a control. Two observations emerged from the analysis of the visual acuity change of this controlled group of paired eyes. The first applies to those eyes in which the visual acuity did not change, either in the treated or untreated group. Of the untreated eyes, for up to 2 years the visual acuity in about two-thirds remained unchanged (65 per cent.) but this figure was almost halved at the end of 4 years (35 per cent.), and these eyes mostly shifted into the "worse" category. As a result, the number of eyes which deteriorated had doubled after 4 years. Among the treated eyes about half (49-9 per cent.) remained unchanged up to 2 years. This figure was also halved at the end of 4 years (to 23'8 per cent.). However, in this group, half of those eyes showed improvement, bringing the overall "improved" figure after 4 years to 64 I per cent. while only 6 6 per cent. showed deterioration, bringing the overall deterioration figure at the 4 years mark to i2 8 per cent. (Fig. 6) The second observation comes from statistical analysis. The x2 analysis of the change in visual acuity of the same paired-eyes group of I03 patients gave P < o-ooi (Table V,  overleaf ) .
This means that there is much less than one chance in I,ooo that there is no difference between the fate of the treated and untreated eyes for this series. Fig. 7 contrasts the change in visual acuity of I03 eyes which stayed paired during the trial.
Encouraging results, apart from our own previous report regarding 44 eyes affected by maculopathy (Rubinstein and Myska, 1972) We wish to thank Dr. J. Marsters for his help with the statistical analysis.
